Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that excels at turning cash into shareholder value and two best left off your watchlist.
Two Stocks to Sell:
Lennar (LEN)
Trailing 12-Month Free Cash Flow Margin: 2.4%
One of the largest homebuilders in America, Lennar (NYSE: LEN) is known for constructing affordable, move-up, and retirement homes across a range of markets and communities.
Why Should You Sell LEN?
- Backlog has dropped by 9.2% on average over the past two years, suggesting it’s losing orders as competition picks up
- Earnings per share fell by 8.9% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
Lennar is trading at $89.50 per share, or 13x forward P/E. Dive into our free research report to see why there are better opportunities than LEN.
Verisk (VRSK)
Trailing 12-Month Free Cash Flow Margin: 36.3%
Processing over 2.8 billion insurance transaction records annually through one of the world's largest private databases, Verisk Analytics (NASDAQ: VRSK) provides data, analytics, and technology solutions that help insurance companies assess risk, detect fraud, and make better business decisions.
Why Does VRSK Fall Short?
- 1.9% annual revenue growth over the last five years was slower than its business services peers
- Earnings per share lagged its peers over the last two years as they only grew by 9.3% annually
Verisk’s stock price of $179.37 implies a valuation ratio of 22.1x forward P/E. Check out our free in-depth research report to learn more about why VRSK doesn’t pass our bar.
One Stock to Watch:
iRhythm (IRTC)
Trailing 12-Month Free Cash Flow Margin: 2.4%
Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ: IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.
Why Is IRTC Interesting?
- Annual revenue growth of 23.9% over the past two years was outstanding, reflecting market share gains this cycle
- Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 27.5% outpaced its revenue gains
- Free cash flow flipped to positive over the last five years, showing the company is at an important crossroads
At $104.61 per share, iRhythm trades at 290.3x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
